NCT05649059View on ClinicalTrials.gov

Investigating the Effects of Cannabidiol on Social Anxiety Disorder

PHASE4RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

September 30, 2026

Conditions
Phobia, Social
Interventions
DRUG

Cannabidiol

Participants randomized to the cannabidiol arm will receive 3mL of Epidiolex (100mg cannabidiol/mL) in a single-dose.

DRUG

Placebo

Participants randomized to the placebo arm will receive 3mL of placebo (sesame seed oil) in a single dose.

Trial Locations (1)

02139

RECRUITING

Massachusetts Institute of Technology, Cambridge

All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

lead

Massachusetts Institute of Technology

OTHER